Amicus Therapeutics, Inc.

FOLDNASDAQHealthcare

$14.49

+$0.00(+0.00%)

Market Cap$4.5B

P/E Ratio—

52W High$14.5

52W Low$5.51

Avg Volume4.2M

Open$14.49

Beta0.48

Cash on Hand Financials Revenue

Amicus Therapeutics, Inc. (FOLD) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

FOLD · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$293.5M▲ +17.4% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$214.0M

cashAndCashEquivalents

Short-Term Investments

$79.5M

shortTermInvestments

YoY Change vs Prior Year

+17.4%

vs prior fiscal year

Latest Quarter

$293.5M

Q4 2025

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$293.5MCash on Hand

Total Debt$483.3MTotal Debt

Net Cash / Net Debt−$189.8MNet Debt Position

Cash vs Debt Ratio

Cash 38%Amicus Therapeutics, Inc. cash as % of market cap: 6.45%% · MCap $5BDebt 62%

Amicus Therapeutics, Inc. carries a net debt position of $189.8M. Total debt ($483.3M) exceeds cash on hand ($293.5M). Amicus Therapeutics, Inc. cash vs debt ratio: 38% cash / 62% debt.

Net Cash = Cash & ST Investments − Total Debt$293.5M − $483.3M = −$189.8M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

FOLD annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

FOLD cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$293.5M+17.4%

Dec 31, 2024FY$249.9M-12.7%

Dec 31, 2023FY$286.2M-2.5%

Dec 31, 2022FY$293.6M-39.2%

Dec 31, 2021FY$482.5M-0.2%

FOLD cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

FOLD vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Amicus Therapeutics, Inc.YOU

FOLD

$293.5M$5B6.5%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Amicus Therapeutics, Inc. (FOLD) cash on hand as of December 31, 2025 is $293.5M, comprising $214.0M in cash and cash equivalents (CCE) plus $79.5M in short-term investments — reported as Amicus Therapeutics, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Amicus Therapeutics, Inc. cash reserves or cash position.

Amicus Therapeutics, Inc. annual cash on hand history shows increased +17.4% in 2025: increased +17.4% in 2025. Amicus Therapeutics, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Amicus Therapeutics, Inc. carries total debt of $483.3M against cash of $293.5M, resulting in a net debt position of -$189.8M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

FOLD cash on hand · 5 questions

As of December 31, 2025, Amicus Therapeutics, Inc. (FOLD) has $293,536,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $214,010,000 in cash and cash equivalents (CCE) plus $79,526,000 in short-term investments. Latest quarter (December 31, 2025): $293,536,000. Data sourced from the annual 10-K filing via FMP.

FOLD cash on handFOLD cash reservesFOLD cash 2025how much cash does FOLD have

▸ Source: FMP /balance-sheet-statement · US GAAP · Amicus Therapeutics, Inc. · Amicus Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025